The Patent Finder

Therapeutic Human Polyclonals Inc.

Also on record
Records under this name other than the patents Therapeutic Human Polyclonals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 6 of 6 · Back to Therapeutic Human Polyclonals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,354,568Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin
Term ended
Term ended Aug 2, 2026 · USPTO record
Term endedTerm ended Aug 2, 2026USPTO record
US 7,585,668Humanized immunoglobulin loci
Term ended
Term ended Jan 20, 2026 · USPTO record
Term endedTerm ended Jan 20, 2026USPTO record
US 8,410,333Humanized immunoglobulin loci
Term ended
Term ended Jul 15, 2024 · USPTO record
Term endedTerm ended Jul 15, 2024USPTO record
US RE47,131Humanized immunoglobulin loci
Term ended
Term ended Jul 15, 2024 · USPTO record
Term endedTerm ended Jul 15, 2024USPTO record
US 7,129,084Production of humanized antibodies in transgenic animals
Term ended
Term ended Sep 24, 2021 · USPTO record
Term endedTerm ended Sep 24, 2021USPTO record
US 8,652,842Humanized immunoglobulin loci
Surrendered on reissue
Surrendered on reissue Nov 20, 2018 · USPTO record
Surrendered on reissueSurrendered on reissue Nov 20, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited